Frank LoVecchio, DO
| Dr. LoVecchio is the recipient of a multi-site grant in cooperation with UCLA and other Universities that examines the clinical management for common skin and soft-tissue infections caused by a treatment resistant bacterium. This is a significant community health issue for all hospitals. Dr. LoVecchio’s longstanding participation in research is evidenced by several key projects whose inception dates span over a decade! With a wide range of research interests, his recent work has focused on eliminating methicillin-resistant Staphylococcus aureus (MRSA) and the types of antibiotics used in MRSA treatment. Staphylococcus is a very well known genus of bacteria. A common pathogen, boils, acne, wound infections, food poisoning are among a host of conditions caused by this organism. The organism is both pathogenic and invasive. It produces leukotoxin that can kill white blood cells and a wide variety of other toxins. Increasingly, and especially in hospital, strains of both S. aureus and S. epidermidis have become resistant to the antibiotic DOC, methicillin. Such strains have been labeled Staph MR. Developing effective clinical management of these bacterial strains is important to our hospital systems.
A native of New York, New York Dr. LoVecchio received a B.A. from the State University of New York at Stony Brook, a D.O from the New York College of Osteopathic Medicine and M.P.H. from Harvard Medical School of Public Health. He then completed postgraduate training in emergency medicine and toxicology. Dr. LoVecchio is currently an attending physician at Maricopa Integrated Health System, Banner Good Samaritan Medical Center, and Phoenix Children’s Hospital and holds certifications in multiple areas including emergency medicine, toxicology and trauma life support. He is passionate about his clinical work, the education of existing and future physicians as well as broadening our knowledge of emergency medicine via cutting edge research. Dr. LoVecchio has authored more than twenty-five scholarly publications, numerous book chapters, and actively participates in peer reviews for several journals and book chapters. His wide-ranging interests include ketone levels in the lungs and blood, and pesticide exposures and scorpion stings in young children. He is currently the primary investigator on four prestigious National Institute of Health (NIH) Grants, including one of the largest Emergency Medicine Grants ever awarded by the NIH.
Dr. LoVecchio is also recognized for his commitment to education and has received nearly thirty awards for teaching and speaking, including: best teacher, best speaker, greatest contributor to the Emergency Medicine program, professor of the year, and educator of the year. He currently holds a faculty position at the Arizona College of Osteopathic Medicine at Midwestern University and contributes to physician postgraduate education by his involvement as an Advanced Trauma Life Support Instructor and holding lectures aimed at teaching emergency medicine physicians important techniques such as “Ultrasound in the Emergency Department”. Dr. LoVecchio has been the invited keynote speaker at several conferences and is recognized internationally for his contributions to the field of emergency medicine.
MIHS on Facebook